Skip to content

4Accepted Jul 20, 9:51 PM ET

Schneiderman Daniel H 4

AZRXAzurRx BioPharma, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

9:51 PM

Jul 20, 2020

Filed

Jul 20, 2020

Documents

1

Size

11.4 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.